Related Experiment Videos

Mecillinam in cerebrospinal fluid in children

Clinical Pharmacokinetics
|November 1, 1981
PubMed

Insights

Mecillinam, a new antibiotic, poorly penetrates the cerebrospinal fluid (CSF) in children with non-inflamed meninges. Higher CSF concentrations were observed in a child with suspected inflamed meninges, suggesting altered barrier permeability.

Area of Science:

  • Pharmacology
  • Infectious Diseases
  • Neurology

Background:

  • Mecillinam is a novel beta-lactam antibiotic.
  • Understanding antibiotic penetration into the central nervous system is crucial for treating meningitis.

Purpose of the Study:

  • To investigate mecillinam's penetration into cerebrospinal fluid (CSF) in pediatric patients.
  • To evaluate the influence of meningeal inflammation on mecillinam CSF concentrations.

Main Methods:

  • Single intravenous dose of mecillinam (30mg/kg) administered to 11 children.
  • CSF and serum concentrations of mecillinam were measured at various time points.
  • Comparison of CSF levels in children with presumed non-inflamed meninges versus one child with suspected inflamed meninges.

Main Results:

  • A mean CSF concentration of approximately 0.30 micrograms/ml was achieved 30 minutes post-dose in children with non-inflamed meninges.
  • Mecillinam CSF levels remained relatively stable for 4 hours despite declining serum concentrations, indicating slow equilibration across the blood-liquor barrier.
  • One child with suspected inflamed meninges exhibited a significantly higher CSF concentration (12.1 micrograms/ml).

Conclusions:

  • Mecillinam demonstrates poor penetration into the CSF of children with non-inflamed meninges.
  • Similar to other penicillins, mecillinam's passage across the blood-liquor barrier is limited under normal conditions.
  • Inflammation of the meninges appears to enhance mecillinam's CSF penetration.

Related Concept Videos